Key | % Net Assets |
---|---|
AstraZeneca | 6.9% |
Vodafone Group | 5.5% |
Resolution | 5.1% |
GlaxoSmithKline | 5.0% |
Other | 77.5% |
Name | % Net Assets |
---|---|
AstraZeneca | 6.9% |
Vodafone Group | 5.5% |
Resolution | 5.1% |
GlaxoSmithKline | 5.0% |
BP | 5.0% |
Rentokil Initial | 4.1% |
Morrison Supermarkets | 4.0% |
Lloyds Banking Group | 3.8% |
Royal Bank of Scotland Group | 3.5% |
Barclays | 3.4% |
Key | % Net Assets |
---|---|
Financials | 30.30% |
Health Care | 18.30% |
Consumer Services | 17.60% |
Telecommunications | 10.20% |
Oil & Gas | 7.90% |
Date | 18-Apr-2024 |
---|---|
NAV | 136.80p |
Currency | GBP |
Change | 0.60p |
% | 0.44% |
YTD change | -1.00p |
YTD % | -0.73% |
Fund Inception | 04/11/2005 |
---|---|
Fund Manager | Thomas See |
TER | 1.66 (28-Feb-2012) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | n/a |
Savings | £50 |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.16 |
You are here: research